false 0001040130 0001040130 2021-07-26 2021-07-26
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): July 26, 2021
 
PetMed Express, Inc.
 (Exact name of registrant as specified in its charter)
Florida
 
000-28827
 
65-0680967
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
 
420 South Congress Avenue, Delray Beach, FL 33445
(Address of principal executive offices) (Zip Code)
 
 
(561) 526-4444
(Registrant’s telephone number, including area code)
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $.001 per share PETS NASDAQ Global Select Market
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
 
Emerging growth company
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
 

 
Item 2.02   Results of Operations and Financial Condition.
 
On July 26, 2021, PetMed Express, Inc. (the “Company”) discussed its financial results for the quarter ended on June 30, 2021. A copy of this conference call transcript is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
 
The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing.
 
Item 9.01   Financial Statements and Exhibits.
 
 
(d)
Exhibits.
     
   
99.1 – PetMed Express, Inc. conference call transcript dated July 26, 2021.
104 – Cover Page Interactive Data File (formatted as Inline XBRL).
 
EXHIBIT INDEX
 
Exhibit No.
 
Description
 
       
99.1
 
PetMed Express, Inc. conference call transcript dated July 26, 2021.
 
104   Cover Page Interactive Data File (formatted as Inline XBRL).  
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: July 27, 2021
 
 
PETMED EXPRESS, INC.
     
 
By:
/s/ Bruce S. Rosenbloom
 
Name:
Bruce S. Rosenbloom
 
Title:
Chief Financial Officer
     
 
2